Wellington Shields Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Wellington Shields Capital Management's RGEN Position: Q4 2023 in Review
Wellington Shields Capital Management sold out of Repligen (RGEN) in Q4 2023, closing a stake of 2,300 shares — an estimated $366K sold.
Wellington Shields Capital Management first reported a position in RGEN in Q3 2020 and held it in 13 quarters. The position peaked at $722K in Q3 2021. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.
- Wellington Shields Capital Management reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
- Wellington Shields Capital Management sold 2,300 Repligen shares in Q4 2023, an estimated $366K.
- Wellington Shields Capital Management first reported a position in Repligen in Q3 2020 and held it in 13 quarters.
- Wellington Shields Capital Management's Repligen position peaked at $722K in Q3 2021.
- 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.
Based on Wellington Shields Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.